Search research articles
Contact Us
Filters
Showing results (251-260 of 282) with videos related to
Page
of 29
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 29, 2019
Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC
Steven H Lin, Yan Lin, Luyang Yao, et al.
JCO Precision Oncology
|
January 30, 2023
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall Survival
Brian De, Ahsan S Farooqi, Kyle G Mitchell, et al.
Journal of the National Cancer Institute
|
April 13, 2011
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy
Xifeng Wu, Yuanqing Ye, Rafael Rosell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 4, 2024
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma
Kelsey L Corrigan, Ting Xu, Yuki Sasaki, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2025
Bayesian Learning to Reduce Cardiac Risk for Locally Advanced NSCLC Patients Based on Personalized Radiotherapy Prescription
Ruitao Lin, Mei Chen, Xiaodong Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 4, 2026
CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer
Amgad Muneer, Eman Showkatian, Yuliya Kitsel, et al.
Cancer Research
|
May 25, 2013
Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers
Xifeng Wu, Liang Wang, Yuanqing Ye, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 22, 2026
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trial
Tingshi Su, Ting Xu, Mei Chen, et al.
The Lancet. Oncology
|
May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Y Chang, Suresh Senan, Marinus A Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2020
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer
Steven H Lin, Brian P Hobbs, Vivek Verma, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 282) with videos related to
Sort By:
Page
of 29
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 29, 2019
Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC
Steven H Lin, Yan Lin, Luyang Yao, et al.
JCO Precision Oncology
|
January 30, 2023
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall Survival
Brian De, Ahsan S Farooqi, Kyle G Mitchell, et al.
Journal of the National Cancer Institute
|
April 13, 2011
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy
Xifeng Wu, Yuanqing Ye, Rafael Rosell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 4, 2024
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma
Kelsey L Corrigan, Ting Xu, Yuki Sasaki, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2025
Bayesian Learning to Reduce Cardiac Risk for Locally Advanced NSCLC Patients Based on Personalized Radiotherapy Prescription
Ruitao Lin, Mei Chen, Xiaodong Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 4, 2026
CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer
Amgad Muneer, Eman Showkatian, Yuliya Kitsel, et al.
Cancer Research
|
May 25, 2013
Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers
Xifeng Wu, Liang Wang, Yuanqing Ye, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 22, 2026
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trial
Tingshi Su, Ting Xu, Mei Chen, et al.
The Lancet. Oncology
|
May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Y Chang, Suresh Senan, Marinus A Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2020
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer
Steven H Lin, Brian P Hobbs, Vivek Verma, et al.
Page
of 29